International Spirits & Beverage Group, Inc. (OTCQB: ISBG): Low Price Cannabis Stock Investment Opportunity
Palm Beach, FL -- January 25, 2019 -- InvestorsHub NewsWire -- (Hotmjstocks.com NEWMJPLAY) — Hotmjstocks.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the growing cannabis market, reports on International Spirits & Beverage Group, Inc. (OTCQB: ISBG).
One of the fastest growing investment areas globally is the cannabis industry. New investment opportunities are being led by companies such as ISBG, International Spirits & Beverage Group, Inc. ISBG has a successful investment portfolio of spirits and is diversifying into products such as CBD oil, CBD edible products – in particular the CBD Gummies. ISBG has been gearing itself up to launch a series of CBD products in January 2019 with targeted plans to reach a significant market share.
Cannabidiol, commonly known as CBD, has been scientifically proven to be the marijuana compound that provides health benefits backed up by an increasing number of governments and local administrations putting in place structures for manufacture and trading with successful results. The growth in the cannabis industry has been phenomenal. Demand for CBD life products related to health benefits is rising which provides some exciting opportunities for investors in MJ stocks.
ISBG is keen to embrace support not only with the industry but also within the cannabis community nationally and internationally. Investments are available as penny stocks that provide minimal investment risks with the promise of healthy dividends should prices rise as predicted.
The cannabis industry is expected to double in size to $21bn by 2021 in the US alone. Globally markets are opening for a growing range of CBD products with other companies entering the cannabis industry including long established pharmaceutical manufacturers recognising the market opportunities. The advantage of ISBG cannabis products are the potential for high prices and generous dividends.
Their product range is soon to include CBD infused drinks. As a company established in the drinks industry ISBG is well placed to understand market developments and hence made plans for increasing their range of products. Slow moves by already established large players to enter this market has led to ISGB’s plans and goals to be market leaders of CBD infused drinks , and their aspiration to be a dominant leader may not be fanciful.
Competition in the cannabis industry has been restricted because of licensing requirements making entry into markets a lot more difficult for new companies. There is a lot of interest, in particular from potential micro businesses who may be able to attract local demand but government transportation rules restrict the opportunities for growth. ISBG has the advantage over a number of competitors to have flexible approaches to decision making and ahead of the game in research, development and product launch plans.
Some large companies diversifying into the cannabis industry are restricted by cumbersome decision making processes and risk averse which is demonstrated by small commitments to entering this market. Added to which, prices changes to stocks can be attributed to a range of factors. An established brand in the drinks sector diversification into CBD products is a natural complement to the spirits and wines already available, especially CBD edible products.
It will be interesting to see how ISBG progress. The indications are full of promise because of an already established reputation and a sensible strategic vision that has been well informed. Time will tell as to how ISBG stocks perform but at the current competitive prices the likelihood of good returns for investors is healthy.
In Other News
Canadian pot producer Tilray (TLRY) on Tuesday said it would acquire cannabis cultivator Natura Naturals Holdings. Tilray stock and other marijuana stocks were mixed, though Cronos Group(CRON) cleared a buy point intraday. Tilray said the deal will likely close in the next 30 days. Once the deal closes, Tilray will pay 35 million Canadian dollars ($26.2 million) — 15 million in cash and 20 million in Tilray stock.
Tilray also said it could also pay Natura up to 35 million Canadian dollars more in stock if Natura hits certain production targets. That would bring the total purchase price of the deal to 70 million Canadian dollars.
As marijuana shortages strain Canada's recreational market, Cowen analysts noted the deal would roughly double Tilray's production capacity. Cowen also provided a "fairness opinion" to Tilray's board in connection with the deal.
The acquisition would give Tilray a 662,000 square-foot greenhouse cultivation facility run by Natura. Tilray said 155,000 square feet in that facility are currently licensed.
"Through an extensive and thorough search for the right supply partner, we're pleased to have come to a mutually-beneficial agreement with Natura," Tilray CEO Brendan Kennedy said in a statement.
Hotmjstocks.com is not a registered investment advisor or a broker-dealer. Investors should not rely on information given by Hotmjstocks.com to make investment decisions; rather, investors should use the information as a starting point to do additional independent research so that they are able to make their own investment decision. Any materials provided by Hotmjstocks.com should never be construed as an offer or solicitation to buy, sell, or hold securities. The information contained in our reports should be viewed as commercial advertisement and is not intended to be investment advice.